Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair

Related Experiment Video

Updated: Jul 6, 2026

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Ildiko Bock-Marquette1, Ankur Saxena, Michael D White

  • 1Department of Pediatrics, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, Texas 75390-9148, USA.

Nature
|November 27, 2004
PubMed

Insights

Thymosin beta4 peptide enhances cardiac cell migration and survival, promoting heart repair. This peptide activates a key pathway, offering a potential new therapeutic target for acute myocardial damage.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Molecular Cardiology

Background:

  • Heart disease is a major cause of mortality in both neonates and adults.
  • Current cardiac repair strategies often rely on stem cell transplantation.
  • The need for novel therapeutic targets for myocardial repair is critical.

Purpose of the Study:

  • To investigate the role of thymosin beta4 (Tβ4) in promoting cardiac cell migration and survival.
  • To elucidate the molecular mechanisms underlying Tβ4's effects on cardiomyocytes.
  • To evaluate Tβ4's therapeutic potential in a mouse model of myocardial infarction.

Main Methods:

  • Assessed Tβ4's effects on embryonic and postnatal cardiomyocyte migration and survival in vitro.
  • Investigated the interaction of Tβ4 with PINCH and integrin-linked kinase (ILK).
  • Utilized a mouse model of coronary artery ligation to study Tβ4 treatment in vivo.

Main Results:

  • Tβ4 significantly promoted myocardial and endothelial cell migration and enhanced cardiomyocyte survival.
  • Tβ4 formed a complex with PINCH and ILK, activating the Akt (protein kinase B) survival pathway.
  • In vivo, Tβ4 treatment upregulated ILK and Akt activity, improved myocyte survival, and enhanced cardiac function post-myocardial infarction.

Conclusions:

  • Thymosin beta4 facilitates cardiomyocyte migration, survival, and cardiac repair.
  • The Tβ4-regulated pathway involving PINCH, ILK, and Akt represents a promising therapeutic target for acute myocardial damage.
  • Tβ4 demonstrates potential as a novel therapeutic agent for heart repair.

More Related Videos

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity08:00

Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity

Published on: July 10, 2019

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: